Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [41] Establishing pre-analytical requirements and maximizing peptide recovery in the analytical phase for mass spectrometric quantification of amyloid-β peptides 1-42 and 1-40 in CSF
    Forgrave, Lauren M.
    van der Gugten, J. Grace
    Nguyen, Quyen
    DeMarco, Mari L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (02) : 198 - 206
  • [42] A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's Disease
    Arcaro, Marina
    Fenoglio, Chiara
    Serpente, Maria
    Arighi, Andrea
    Fumagalli, Giorgio G.
    Sacchi, Luca
    Floro, Stefano
    D'Anca, Marianna
    Sorrentino, Federica
    Visconte, Caterina
    Perego, Alberto
    Scarpini, Elio
    Galimberti, Daniela
    BIOMEDICINES, 2022, 10 (10)
  • [43] Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
    Schneider, Lon S.
    Kennedy, Richard E.
    Cutter, Gary R.
    ALZHEIMERS & DEMENTIA, 2010, 6 (05) : 367 - 377
  • [44] beta-Amyloid (1-42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
    Kaiser, Elmar
    Thomann, Philipp A.
    Essig, Marco
    Schroeder, Johannes
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 393 - 401
  • [45] Amyloid beta 1–42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer′s disease
    Yat Fung Shea
    Leung-wing Chu
    Ming-yee Maggie Mok
    Man-Fai Lam
    Journal of Nephrology, 2014, 27 : 217 - 220
  • [46] Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease ( vol 16 , 139 , 2024)
    Arranz, Javier
    Zhu, Nuole
    Rubio-Guerra, Sara
    Rodriguez-Baz, Inigo
    Ferrer, Rosa
    Carmona-Iragui, Maria
    Barroeta, Isabel
    Illan-Gala, Ignacio
    Santos-Santos, Miguel
    Fortea, Juan
    Lleo, Alberto
    Tondo, Mireia
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [47] Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease
    Almdahl, Ina S.
    Lauridsen, Camilla
    Selnes, Per
    Kalheim, Lisa F.
    Coello, Christopher
    Gajdzik, Beata
    Moller, Ina
    Wettergreen, Marianne
    Grambaite, Ramune
    Bjornerud, Atle
    Brathen, Geir
    Sando, Sigrid B.
    White, Linda R.
    Fladby, Tormod
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [48] Neurodegenerative disease biomarkers Aβ1-40, Aβ1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relationto normal aging, genetic influences, and cerebral amyloid angiopathy
    Chen, Jason A.
    Fears, Scott C.
    Jasinska, Anna J.
    Huang, Alden
    Al-Sharif, Noor B.
    Scheibel, Kevin E.
    Dyer, Thomas D.
    Fagan, Anne M.
    Blangero, John
    Woods, Roger
    Jorgensen, Matthew J.
    Kaplan, Jay R.
    Freimer, Nelson B.
    Coppola, Giovanni
    BRAIN AND BEHAVIOR, 2018, 8 (02):
  • [49] Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study
    Lerche, Stefanie
    Wurster, Isabel
    Roeben, Benjamin
    Machetanz, Gerrit
    Zimmermann, Milan
    Bernhard, Felix
    Stransky, Elke
    Deuschle, Christian
    Schulte, Claudia
    Hansson, Oskar
    Zetterberg, Henrik
    Gasser, Thomas
    Berg, Daniela
    Maetzler, Walter
    Brockmann, Kathrin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (02) : 165 - 170
  • [50] Detection of Alzheimer's disease amyloid beta 1-42, p-tau, and t-tau assays
    van Harten, Argonde C.
    Wiste, Heather J.
    Weigand, Stephen D.
    Mielke, Michelle M.
    Kremers, Walter K.
    Eichenlaub, Udo
    Dyer, Roy B.
    Algeciras-Schimnich, Alicia
    Knopman, David S.
    Jack Jr, Clifford R.
    Petersen, Ronald C.
    ALZHEIMERS & DEMENTIA, 2022, 18 (04) : 635 - 644
12345